Tashin Pharmaceutical (Stock Code: 6838), a company in the biotechnology and medical industry, announced its revenue for April 2026. The company generated NT$0 thousand (NT$0.00 million) in revenue for the month. No year-over-year comparison data was provided.

FACT BOX

  • Source: PR Times
  • Category: News